On behalf of the Scientific Committee for the American Pediatric Meeting, we are pleased to invite you to attend the "2nd Neonatal Review Course and the 1st American Pediatric Meeting" to be held in Lithuania - Vilnius April 20-22, 2018. This superb conference features outstanding internationally known neonatologists and pediatricians from premier medical universities in the United States. The conference will be discuss new updates, as well as the approach and management of a variety of pediatric diseases in multiple subspecialties.
Crown Plaza Vilnius
Lithuania - Vilnius
Friday to Sunday (07:00 AM to 04:00 PM)
20 - 22 April 2018
Dr. Armsby is currently an Associate Professor of Pediatrics at Oregon Health & Sciences University (OHSU). She has directed the Pediatric Cardiology Fellowship Program at OHSU since 2006, and has been interim Division Head of Pediatric Cardiology since 2014.
Her primary clinical specialty is in Interventional Cardiology. In addition she maintains a busy general pediatric cardiology clinic, is the medical director of the Pediatric Dyslipidemia Program, and manages the care of children following heart transplantation.
She has served as faculty on the AAP NeoPREP Review Course, the Neonatal Specialty Review Course and the 1st Neonatal Review Course in Dubai. In addition, she serves on the faculty and Planning Committee of the AAP Pediatric Cardiology Board Review Course.
My name is Amy and I am a pediatric gastroenterologist currently working at Doernbecher Children's Hospital in Portland Oregon. I was trained at the University of New Mexico for medical school and residency then trained at Washington University in St. Louis for my GI fellowship. I have been at Doernbecher since completion of my training. My main focus aside from the GI tract is teaching and I love to do this with any chance I get. I am in charge of making sure our newly second year medical students get a good foundation on the structure, function and pathology of the GI tract as part of our YourMD curriculum. Clinically I have a strong interest and passion for the care of patients with cystic fibrosis and short bowel syndrome where I can emphasize the importance of nutrition in our patient care.
Gregory Redding, MD, is chief of the Division of Pulmonary Medicine at Seattle Children's Hospital and a Professor of Pediatrics and director of the Pediatric Pulmonary Training Center at the University of Washington School of Medicine. He earned his MD from Stanford University. He completed a pediatrics residency at UCLA and a pediatric pulmonary fellowship at the University of Colorado. Dr. Redding's career in pulmonary medicine spans 40 years during which he has conducted research in asthma, bronchiolitis, empyema, cystic fibrosis, bronchiectasis, and most recently spine and thoracic cage disorders in young children. He has published more than 200 articles, reviews and chapters. He received the Edwin Kendig Lifetime Achievement Award in Pediatric Pulmonary Medicine by the American Academy of Pediatrics in 2015 His training philosophy is to ensure critical thinking and creative application of physiologic principles to clinical problems. He is a consultant to the Maternal-Child Health Bureau on national leadership training for health-care professionals.
Dr. Connelly provides clinical care for patients with a wide variety of endocrinology disorders. She cares for children and adolescents with type 1 and type 2 diabetes mellitus at the Harold Schnitzer Diabetes Health Center, and also sees patients with other general endocrinology disorders at Doernbecher Children's Hospital. She holds a clinical interest in caring for children with disorders of sex development and in providing medical care for gender non-conforming children and adolescents. She is the medical director of the Doernbecher Gender Clinic and the co-director of the Doernbecher Sex Development Clinic. Dr. Connelly is also active in teaching and education, and serves as the rotation director for pediatric residents and students on the Pediatric Endocrinology rotation. In her spare time, Dr. Connelly enjoys spending time with her husband, two daughters and friends. She enjoys playing outside, hiking and camping, and enjoying outdoor music events.
Chief, Neonatology and Newborn Services Division
Department of Pediatrics
Children’s of Mississippi
University of Mississippi Medical Center
Dr. Renate Savich is a Professor of Pediatrics and Chief, Neonatology and Newborn Services Division, Department of Pediatrics at Children’s of Mississippi University of Mississippi Medical Center. She is also currently the Past-Chair of the Section of Neonatal-Perinatal Medicine, American Academy of Pediatrics and on the Editorial Board of NeoReviews. She is also on the Executive Committee of the Mississippi State Perinatal Quality Collaborative. Her interests include neonatal respiratory physiology, neonatal nutrtion, health disparities, medical education and simulation training, and quality improvement in the NICU. She recently received NIH funding to perform widespread genetic testing on neonates in the Deep South.
Dr. Savich received her medical degree from Northwestern University, Chicago, Illinois. She received further training in Pediatrics from Children’s Memorial Hospital, Northwestern University, Chicago, IL. She completed her fellowship in Neonatal/Perinatal Medicine in 1988 from the University of California, San Francisco.
Some of her publications in the field of neonatology and medicine are:
Hematology / Oncology
Hematology / Oncology
Dr. Kellie Nazemi is the Medical Director of the Pediatric Brain Tumor Program at OHSU Doernbecher Children's Hospital in Portland, Oregon. She completed her fellowship training at The Dana-Farber Cancer Institute / Children's Hospital Boston in 2006. She is an active member of the Children's Oncology Group (COG), a National Cancer Institute supported clinical trials group devoted exclusively to pediatric cancer research. She is the OHSU Principal Investigator for all COG clinical trials in patients with central nervous system tumors. She has developed an extensive collaborative network with national leaders and peers in the field. She is also the Principal Investigator (PI) for OHSU in the Pediatric Neuro-Oncology Consortium (PNOC). The PNOC is a network of fifteen children's hospitals that conduct clinical trials of new therapies for children with brain tumors, with the goal of improving outcomes by translating the latest findings in cancer biology into better treatments. She has a particular interest in new treatment strategies for patients with diffuse intrinsic pontine glioma (DIPG) and high-risk medulloblastoma that incorporate the rapidly evolving molecular understanding of these devastating childhood cancers. She is co-Principal Investigator for PNOC-003, a novel clinical trial design to develop a personalized medicine approach for children with newly diagnosed DIPG. She also serves as an active member of the OHSU Knight Cancer Institute Data Safety & Monitoring Committee.
Dr. Louise Vaz completed her Bachelor’s of Science in a self-designed curriculum in Infectious Diseases at Duke University. She earned her medical degree from the Vanderbilt School of Medicine, in Nashville, Tennessee and was a member of Alpha Omega Alpha Honor Medical Society. She completed her residency in pediatrics at the Seattle Children’s Hospital/University of Washington, and two fellowships at Boston Children’s Hospital, in Boston, Massachusetts: one in pediatric infectious diseases and the other in pediatric health services research. She also has a master’s degree in public health from the Harvard School of Public Health. She is board certified in pediatrics and pediatric infectious diseases.
Dr. Vaz is an Assistant Professor of Pediatric Infectious Diseases at Oregon Health & Science University (OHSU). She attends on the inpatient infectious disease service and sees outpatients in infectious disease clinic. Her clinical areas of expertise include global and refugee health, outpatient antibiotic therapy, judicious antibiotic use, and treatment of complex surgical infections.
At Doernbecher Children’s Hospital, Dr. Vaz is medical director of the Outpatient Parenteral Antibiotic Therapy program, which helps children and families transition from the inpatient to outpatient setting for further treatment of their infection. She is also pediatric medical director for Clinical Integration at the OHSU-Partners level which oversees large scale system wide population health and quality improvement efforts.
Her area of research is in optimizing transitions of care to improve pediatric health outcomes. Her focus is in identifying social vulnerabilities at the family level that can lead to increased health care utilization and care coordination in the transition period. Her role with OPAT enables multi-disciplinary collaborations with medical, surgical and psychosocial care providers to improve care delivery across Oregon. Her work includes measuring the value of care coordination, improving the discharge process, and understanding parent values in health care decision making. She is interested in developing innovative methods of care delivery particularly in poor and under resourced areas.
Dr. Qubty is a board certified Child Neurologist and Assistant Clinical Professor at the University of California in San Francisco. He received his medical degree from University of Texas in Houston. He completed a combined residency in Pediatrics and Child and Adolescent Neurology at the Mayo Clinic in Rochester, Minnesota. He has completed a fellowship and certification in headache medicine. He is actively involved in pediatric migraine clinical trials.
Crown Plaza Vilnius, Lithuania - Vilnius